Clinical trial

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

NCT03164486

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-11-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2016-11-01Date precision: month

Registry last updated2026-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Carcinomaunresolved

Colorectal Carcinomaunresolved

Lung Carcinomaunresolved

Metastatic Malignant Neoplasm in the Breastunresolved

Metastatic Malignant Neoplasm in the Colonunresolved

Metastatic Malignant Neoplasm in the Lungunresolved

Metastatic Malignant Neoplasm in the Rectumunresolved

Pancreatic Carcinomaunresolved

Interventions

18F-αvβ6-BPDRUG

Sponsors & collaborators

Julie L. Sutcliffe, Ph.Dlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

SacramentoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03164486 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.